EFFECT OF CIRCUIT TRAINING ON BONE MINERAL DENSITY IN POST MENOPAUSAL PERIOD

Launched by CAIRO UNIVERSITY · Apr 25, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how circuit training, which is a type of exercise that involves a series of activities performed one after another, can affect bone health in postmenopausal women. The goal is to see if participating in this kind of exercise can help improve bone mineral density, which is important for preventing osteoporosis—a condition that makes bones weak and more likely to break.

To be eligible for the study, women need to be between the ages of 50 and 60, have been postmenopausal for at least a year, and have a body mass index (BMI) of less than 30. They should also have low levels of vitamin D and have a specific range of bone density as measured by a test called DEXA. Participants should be able to move around independently and should not have been active in a regular exercise program. However, women with certain health issues, such as thyroid problems, severe anemia, or heart diseases, will not be able to participate. Those who join the study can expect to engage in circuit training sessions and will be monitored for changes in their bone health throughout the trial.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Post menopausal women (at least 12 months after cessation of menstruation. Their ages will range from 50 -60 years old. Their body mass index (BMI) will be less than 30 Kg/m2. All of them have vitamin D potential deficiency (insufficiency) from 30nmol to 50nmol .
• • Their T-score on DEXA will range from -1.1 to -2.4 indicates osteopenia or low bone density.
• • They must be able to ambulate independently. All of them must be sedentary life style.
• Exclusion Criteria:
• All women will be excluded if they have one of the following criteria:
• • Thyroid, kidney and liver dysfunction. Cardiovascular diseases, severe anemia, uncontrolled diabetes mellitus. Any chest surgery, chronic obstructive pulmonary disease, malignancy. Renal failure, myocardial infarction, myasthenia gravis, hyperthyroidism. Hemorrhage, acute viral disease, acute tuberculosis, mental disorders, or those with pacemakers.
• • Musculoskeletal disorders or women who received corticosteroids in the last 6 months prior to the study.